APOB and hyperlipidemia: It has been demonstrated that in obese subjects without overt hyperlipidaemia, chylomicron catabolism is impaired [146], and these patients display a combination of overproduction of VLDL-apoB particles and decreased catabolism of apoB containing particles in patients with visceral obesity [147].